NEW YORK--(BUSINESS WIRE)--Pluristem Therapeutics Inc. (NasdaqCM:PSTI) (DAX:PJT), a bio-therapeutics company dedicated to the commercialization of unrelated donor-patient (allogeneic) cell therapy products for a variety of disorders, announced today that Mr. Zami Aberman, President and CEO, has been invited to present at the ILSI-BioMed Conference on the topic “The Placenta - A Matchless Source for Cell Therapy.” The presentation will take place on Tuesday, June 16, 2009 in the BioPharma Session at 5:20-5:40 pm local time, at the David InterContinental Hotel, Tel Aviv, Israel. In addition, Moran Meiron, Ph.D., Pluristem’s Research Director, was invited to present a poster titled “Paracrine and Immunological Characteristics of Placenta Derived MSC like Cells- Possible Mechanism of Action,” which will be on display from June 15 through 17, 2009 at the Posters Hall, in the Dan Panorama Hotel, Tel-Aviv, Israel.
